ACAD
37.59
-0.04
-0.11%
AEMD
1.92
+0.17
+9.41%
APRI
1.68
+0.02
+1.50%
ARNA
25.09
-0.02
-0.08%
ATEC
2.19
+0.06
+2.82%
CNAT
5.38
-0.15
-2.71%
CRXM
0.151
0.00
0.00%
CYTX
0.39
-0.02
-4.79%
DXCM
69.99
+0.49
+0.71%
GNMK
9.52
-0.04
-0.42%
HALO
16.78
+0.18
+1.08%
ILMN
201.41
+1.17
+0.58%
INNV
0.097
-0.003
-3.15315%
INO
6.15
-0.14
-2.23%
ISCO
1.85
+0.05
+2.78%
ISIS
57.56
0.00
0.00%
LGND
135.55
-0.26
-0.19%
LPTN
2.93
-2.93
-100.00%
MBVX
0.67
-0.07
-9.4730%
MEIP
2.75
+0.01
+0.36%
MNOV
6.18
+0.3
+5.10%
MRTX
9.85
-0.5
-4.83%
MSTX
0.13
-0.01
-5.28%
NBIX
58.93
+0.1
+0.17%
NUVA
54.25
-0.36
-0.66%
ONCS
0.97
-0.01
-1.01%
ONVO
1.97
-0.04
-1.99%
OREX
2.12
-0.17
-7.22%
OTIC
3.3
-0.15
-4.35%
QDEL
43.1
-0.03
-0.07%
RCPT
231.96
0.00
0.00%
RGLS
1.31
-0.01
-0.76%
RMD
77.38
+0.06
+0.08%
SCIE
0
0.00
-50.0000%
SPHS
2.25
+0.01
+0.45%
SRNE
1.8
0.00
0.00%
TROV
0.7
+0.02
+2.93%
VICL
2.41
0.00
0.00%
VOLC
18
0.00
0.00%
ZGNX
14.4
+1.35
+10.34%
ACAD
37.59
-0.04
-0.11%
AEMD
1.92
+0.17
+9.41%
APRI
1.68
+0.02
+1.50%
ARNA
25.09
-0.02
-0.08%
ATEC
2.19
+0.06
+2.82%
CNAT
5.38
-0.15
-2.71%
CRXM
0.151
0.00
0.00%
CYTX
0.39
-0.02
-4.79%
DXCM
69.99
+0.49
+0.71%
GNMK
9.52
-0.04
-0.42%
HALO
16.78
+0.18
+1.08%
ILMN
201.41
+1.17
+0.58%
INNV
0.097
-0.003
-3.15315%
INO
6.15
-0.14
-2.23%
ISCO
1.85
+0.05
+2.78%
ISIS
57.56
0.00
0.00%
LGND
135.55
-0.26
-0.19%
LPTN
2.93
-2.93
-100.00%
MBVX
0.67
-0.07
-9.4730%
MEIP
2.75
+0.01
+0.36%
MNOV
6.18
+0.3
+5.10%
MRTX
9.85
-0.5
-4.83%
MSTX
0.13
-0.01
-5.28%
NBIX
58.93
+0.1
+0.17%
NUVA
54.25
-0.36
-0.66%
ONCS
0.97
-0.01
-1.01%
ONVO
1.97
-0.04
-1.99%
OREX
2.12
-0.17
-7.22%
OTIC
3.3
-0.15
-4.35%
QDEL
43.1
-0.03
-0.07%
RCPT
231.96
0.00
0.00%
RGLS
1.31
-0.01
-0.76%
RMD
77.38
+0.06
+0.08%
SCIE
0
0.00
-50.0000%
SPHS
2.25
+0.01
+0.45%
SRNE
1.8
0.00
0.00%
TROV
0.7
+0.02
+2.93%
VICL
2.41
0.00
0.00%
VOLC
18
0.00
0.00%
ZGNX
14.4
+1.35
+10.34%

Headline »

Pub crawl for science 3

September 14th 2017 Pub Crawl for Science Event: Padres Pedal the Cause Fundraiser

August 17, 2017 – 12:39 pm

SDBN was very involved with the April 2017 March for Science San Diego (MSSD), our members marched, volunteered, and sponsored the very successful event with 15,000 participants. The national March for Science organization is still …

Read the full story »

Featured, SDBN Blog »

February SDBN Newsletter: Speed Networking Presentation, Local Events, Blogs, News, Jobs

February 7, 2015 – 10:11 am
test

Click to Read.

Read the full story »

Featured, SDBN Blog »

The Biotech/Pharma Project Manager’s Toolkit Begins January 23rd: Frequently Asked Questions (FAQ’s)

January 20, 2015 – 11:31 am
iStock_chalkboard FAQ2

We’ve been working closely with UCSD Extension to provide customized life science training that SDBN members are seeking, see our recent press release and event. Our first offering begins January 23rd, the Biotech/Pharma Project Manager’s …

Read the full story »

Featured, SDBN Blog »

First SDBN/UCSD Extension Offering To Begin January 2015: Biotech/Pharma Project Manager’s Toolkit

December 11, 2014 – 5:30 pm
15977741865_8a2162af85_m

The San Diego Biotechnology Network was formed in order to serve local life scientists, professionals and organizations and to help the region to not only grow, but thrive. Towards this end, we are working with …

Read the full story »

Breaking San Diego Biotech News

Bio Roundup: RNAi’s Big Day, CAR-T For Kids, Drugs From Fungi & More

September 22, 2017 – 2:30 am

It’s been a year of biomedical milestones in the U.S., including the first approval of a CAR-T cellular immunotherapy, the first smartphone app to treat substance abuse, and the first approval…

[[Click headline to continue reading.]]

Lawyer Sues Venter’s Synthetic Genomics “Boys Club” over Gender Bias

September 20, 2017 – 8:05 pm

Against a contentious backdrop of a gender gap in the life sciences, a lawyer who spent more than eight years managing intellectual property at San Diego’s Synthetic Genomics (SGI) has sued the…

[[Click headline to continue reading.]]

Alnylam Data Puts a Nobel Discovery One Step Closer to Approved Drug

September 20, 2017 – 3:10 am

[Updated with comments at 9:49 am ET, see below] For the first time ever, a medicine using RNA interference, a method of muting a gene before it can make a harmful protein, is headed for an FDA…

[[Click headline to continue reading.]]

On CAR-T’s Edge, Seattle Researchers Plot to Bypass Novartis Therapy

September 19, 2017 – 2:45 am

It’s not a stretch to say that Greta Oberhofer is alive thanks to the genetically modified cell therapy called CAR-T. At three and a half months old, she was diagnosed with acute lymphoblastic…

[[Click headline to continue reading.]]


See All News>>

Newest San Diego Biotech Jobs

Associate Director, Biostatistics (San Diego)

Tocagen is a clinical-stage, cancer-selective gene therapy company focused on developing first-in-class, broadly applicable product candidates designed to activate a patient’s immune system against their own cancer from within.
Every member of our t …

Associate Director, Clinical Data Management (San Diego)

Tocagen is a clinical-stage, cancer-selective gene therapy company focused on developing first-in-class, broadly applicable product candidates designed to activate a patient’s immune system against their own cancer from within.
Every member of our t …

Project Manager (San Diego)

Tocagen is a clinical-stage, cancer-selective gene therapy company focused on developing first-in-class, broadly applicable product candidates designed to activate a patient’s immune system against their own cancer from within.
Every member of our t …

Research Scientist 1, Experimental Virology (San Diego)

Tocagen is a clinical-stage, cancer-selective gene therapy company focused on developing first-in-class, broadly applicable product candidates designed to activate a patient’s immune system against their own cancer from within.
Every member of our t …


See All Jobs>>